NCT05659524 (NOSE) is a NA clinical trial of Nasal saline irrigation in Pituitary Tumor, sponsored by Lori Wood.

Who is sponsoring NCT05659524?

NCT05659524 is sponsored by Lori Wood.

What drugs are being tested in NCT05659524?

Interventions in NCT05659524: Nasal saline irrigation.

What condition does NCT05659524 study?

NCT05659524 studies Pituitary Tumor.

Is NCT05659524 still recruiting?

NCT05659524 is currently recruiting now. Last updated 19 April 2024.

Last reviewed 2024-04-19 · How we verify

NCT05659524: NOSE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery

Recruiting now NA Last updated 19 April 2024

What this trial tests

NA trial testing Nasal saline irrigation in Pituitary Tumor in 140 participants. Currently enrolling.

Timeline

18 December 2020

Primary endpoint
31 December 2028

31 December 2029

Quick facts

Lead sponsor	Lori Wood
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	140
Start date	18 December 2020
Primary completion	31 December 2028
Estimated completion	31 December 2029
Sites	2 locations across United States

Drugs / interventions tested

Nasal saline irrigation

Conditions studied

Pituitary Tumor — all drugs for Pituitary Tumor →

Sponsor

Lori Wood

Who can join

Adults 19 to 85, any sex, with Pituitary Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, single-blinded, multicenter study evaluating the benefit of sinonasal irrigations following endoscopic pituitary surgery. The goal of this study is to create practice changing guidelines with objective data highlighting the importance of irrigations on postoperative outcomes for pituitary surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pituitary Tumor

Currently open trials in the same condition.

NCT06936813 — The PROMISE Survey · active not recruiting
NCT06705036 — Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions · recruiting
NCT06472505 — Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage · NA · recruiting
NCT06523582 — Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients · recruiting
NCT04087902 — Long-Term Longitudinal QoL in Patients Undergoing EEA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05659524 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lori Wood
Last refreshed: 19 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05659524.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing